Wedbush Initiates Coverage On Dianthus Therapeutics With Outperform Rating, Announces Price Target of $23
Wedbush Initiates Coverage On Dianthus Therapeutics With Outperform Rating, Announces Price Target of $23
Wedbush以跑贏大盤的評級啓動對Dianthus Therapeutics的報道，宣佈目標股價爲23美元
Wedbush analyst Laura Chico initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) with a Outperform rating and announces Price Target of $23.
Wedbush分析師勞拉·奇科以跑贏大盤的評級開始對Dianthus Therapeutics（納斯達克股票代碼：DNTH）進行報道，並宣佈目標股價爲23美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。